TrialSiteNews

Join The Conversation! | https://trialsitenews.com/ Dr. Nikolai Petrovsky is a renowned researcher, professor and expert in the field of immunology, endocrinology and vaccine development. He is founder of the vaccine company, Vaxine, a company funded by the US NIH to develop novel vaccine technologies. Dr. Petrovsky has developed a protein subunit vaccine for COVID-19. He also serves as director of endocrinology at Flinders Medical Centre, Australia, and is vice-president and secretary-general of the international immunomics society. Link | https://vaxine.net/

Join The Conversation! | https://trialsitenews.com/ Story 1 | COVID-19 Infection Rate Skyrockets in America’s Most Vaccinated State: Vermont Becker’s Healthcare, a prominent health system-focused online media reported today that Vermont is the most vaccinated state in the nation. Nearly 72% of the entire population of about 630,000 are fully vaccinated. Yet new cases of SARS-CoV-2 skyrocket, including deaths. What is going on? Why does TrialSite continue to see in the most heavily vaccinated nations and several states in the United States inordinately high rates of infection? TrialSite reports a trend observed across America and the world where the most vaccinated populations experienced acceleration in infections, including breakthrough Sars-CoV-2 cases. Link | https://trialsitenews.com/covid-19-infection-rate-skyrockets-in-americas-most-vaccination-state-vermont/ Story 2 | The NIH to Debate Vaccine Mandates There’s an interesting debate happening over vaccine mandates, and it’s in an unlikely place. The National Institute of Health, the workplace of Dr. Anthony Fauci, who is a mandate advocate. According to a November 7th article in The Wall Street Journal, the NIH will hold a “round-table session” on December 1st to discuss the “ethics” of the proposed workplace mandate. Link | https://trialsitenews.com/the-nih-to-debate-vaccine-mandates/

Join The Conversation! | https://trialsitenews.com/ Story 1 | COVID-19 Infection Rate Skyrockets in America’s Most Vaccinated State: Vermont Becker’s Healthcare, a prominent health system-focused online media reported today that Vermont is the most vaccinated state in the nation. Nearly 72% of the entire population of about 630,000 are fully vaccinated. Yet new cases of SARS-CoV-2 skyrocket, including deaths. What is going on? Why does TrialSite continue to see in the most heavily vaccinated nations and several states in the United States inordinately high rates of infection? TrialSite reports a trend observed across America and the world where the most vaccinated populations experienced acceleration in infections, including breakthrough Sars-CoV-2 cases. Link | https://trialsitenews.com/covid-19-infection-rate-skyrockets-in-americas-most-vaccination-state-vermont/ Story 2 | The NIH to Debate Vaccine Mandates There’s an interesting debate happening over vaccine mandates, and it’s in an unlikely place. The National Institute of Health, the workplace of Dr. Anthony Fauci, who is a mandate advocate. According to a November 7th article in The Wall Street Journal, the NIH will hold a “round-table session” on December 1st to discuss the “ethics” of the proposed workplace mandate. Link | https://trialsitenews.com/the-nih-to-debate-vaccine-mandates/

Join The Conversation! | https://trialsitenews.com/ Alain Moussy, CEO of AB Science, discusses their new early-treatment drug for COVID-19: AB Science | https://www.ab-science.com/ Article on drug published in Science | https://www.science.org/doi/10.1126/science.abg5827

The World Council for Health, a coalition of medical and health advocacy focused organizations around the world, launched in September, with a comprehensive guide to successfully treat Covid-19 at home. In this inspiring,informative and empowering introductory interview with TrialSite News’ Shabnam Palesa Mohamed, WCH steering committee members join TSN to share information with the public on the WCH’s vision and mission, affiliates, activities the Council is busy with, exciting upcoming events, how to join and support the WCH, and most importantly, a clear message of truth, trust, health and freedom. For more information, visit www.worldcouncilforhealth.org

Join The Conversation! | https://trialsitenews.com/ Alain Moussy, CEO of AB Science, discusses their new early-treatment drug for COVID-19: AB Science | https://www.ab-science.com/ Article on drug published in Science | https://www.science.org/doi/10.1126/science.abg5827

Join The Conversation! | https://trialsitenews.com/ Brad Hunstable, CEO of Linear Labs and West Point Graduate, lost his 12 year old son Hayden to suicide during the pandemic. He describes it as a perfect storm. In this interview, he talks about Hayden, why it happened, his grieving process, advice for parents, advice for the gaming industry and why conversations are so important. Link to Hayden's Corner | https://haydenscorner.org/

Join The Conversation! | https://trialsitenews.com/ Brad Hunstable, CEO of Linear Labs and West Point Graduate, lost his 12 year old son Hayden to suicide during the pandemic. He describes it as a perfect storm. In this interview, he talks about Hayden, why it happened, his grieving process, advice for parents, advice for the gaming industry and why conversations are so important. Link to Hayden's Corner | https://haydenscorner.org/

What is the science behind vaccination mandates for children when it comes to Covid-19? Watch an interactive discussion between internationally known Virologist Geert Vanden Bossche and TrialSite News as they discuss the pandemic, the science behind vaccinating children, and what this all means in our fight against Covid-19.

Dr Peter McCullough, MD, one of the most cited physicians in the world, an eminent practitioner of internal medicine, a cardiologist and epidemiologist, co-wrote a report with Dr Jessica Rose, Ph.D., a virologist and epidemiologist in Canada, called ‘A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products.’

In this edition of CATalyst, Shabnam Palesa Mohamed hosts Dr Jackie Stone (Harare, Zimbabwe), Dr EV Rapiti (Cape Town, South Africa) and Dr Nathi Mdladla (Tshwane, South Africa). The doctors share their experiences during Covid-19, the impact of Ivermectin in their countries, the hostility they face when challenging the status quo, and, how the HIV-Aids virus prepared Africa to face C-19 with courage and innovation. Their message to doctors in Africa and globally? Stand up for the doctors’ right to heal patients.

Join The Conversation! | https://trialsitenews.com/ Bill Pepitone is a former NYPD police officer and candidate for NYC mayor. Website | https://pepitonefornyc.com/

Join The Conversation! | https://trialsitenews.com/ Bill Pepitone is a former NYPD police officer and candidate for NYC mayor. Website | https://pepitonefornyc.com/

Join The Conversation! | https://trialsitenews.com/ Achal Prabhala on Vaccine Equity and the Role of Gov & Pharmaceutical Companies Achal Prabhala is a researcher, writer and coordinator of AccessIBSA which advocates for equal access to medicines. He is also a fellow of the Shuttleworth Foundation in Bangalore, India.

Join The Conversation! | https://trialsitenews.com/ Achal Prabhala on Vaccine Equity and the Role of Gov & Pharmaceutical Companies Achal Prabhala is a researcher, writer and coordinator of AccessIBSA which advocates for equal access to medicines. He is also a fellow of the Shuttleworth Foundation in Bangalore, India.

In this episode of CATalyst, Shabnam Palesa Mohamed engages scientist Dr Jessica Rose, and medico-legal specialist Dr Herman Edeling. In a must watch conversation, they explore VAERS data, the experience of bringing jab injury data to the attention of authorities, and the catastrophic implications of the ongoing cover up. They also engage the importance of the independent THJ SAVAERS project, lessons learned from the WHO-lead pandemic, and a hopeful message to the public - to reclaim the right to health. #CATalyst #TrialSiteNews #TrialSiteNewsAfrica #TSNA #Health #Science #VAERS #PublicInterest

We are living through an era of unprecedented censorship of scientific dissent and professional discourse. Not a week goes by without highly credentialed scientists, doctors and academics being silenced. The suppressing - in its most benign form - is done through arbitrary removal of social media accounts (Twitter, YouTube and others), however it has also been far more pernicious through orchestrated smear campaigns by sometimes anonymous sources. Join the TrialSite advisory committee as they discuss and debate the causes, consequences and potential solutions to this damaging phenomenon. The webinar will include a period of time for audience derived questions for the panel.

In this borderless episode of CATalyst with Shabnam Palesa Mohamed, we bring together passionate and compassionate doctors from South Africa (Dr Pinky Ngcakani and Dr Shankara Chetty) and North America (Dr George Fareed), in a courageous, no holds barred, long-awaited conversation. They share with TrialSite News Africa: why they chose to become doctors, highlights of their incredible C19 journeys, expertise and challenges with treatments that work, experiences with jab injuries and signs of jab shedding, candid views on the censorship and harassment of doctors, what they would do differently the next time there is a pandemic, and finally, their powerful messages to speak up for the right to health.

Dr. Erin Stair discusses with Dr. Robert Malone about the COVID-19 Spike Protein vs the Spike Protein produced by the COVID-19 Vaccines and more.

Dr. McCullough is an internist, cardiologist and epidemiologist who has been treating COVID-19 patients throughout the pandemic. He has 46 peer-reviewed publications related to COVID-19 and was one of the earliest advocates for early treatment.

TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands. The event was simultaneously broadcast live on YouTube. With a mission to bring transparency and accessibility to clinical research TrialSite continues to track repurposed drugs as a potential option for COVID-19 along with vaccines, novel therapeutics and other measures. Introduction of speakers Introduction - Dr. Martin Gill (2:00) Welcome - Daniel O'Connor (5:37) Ivermectin use in Zimbabwe - Dr. Jackie Stone (9:20) Introduction to Dr. Sabine Hazan (22:50) Early to treat, early to cure - Dr. Sabine Hazan (26:10) Introduction to Dr. David Scheim (36:45) Ivermectin for COVID-19 treatment in Peru - Dr. David Scheim (37:40) Introduction to Dr. Jennifer Hibberd (50:00) World data - Dr. Jennifer Hibberd (51:00) Introduction to Dr. Lucy Kerr (1:03:00) Ivermectin as a prophylaxis and treatment - Dr. Lucy Kerr (1:05:22) Introduction to Dr. Kylie M. Wagstaff (1:17:30) In-vitro investigations of Ivermectin - Dr. Kylie M. Wagstaff (1:18:30) Introduction to Dr. Tess Lawrie (1:34:25) Sharing evidence on Ivermectin - Dr. Tess Lawrie (1:47:52) Questions to the panel (1:48:20) Closing keynote - Dr. Colleen Aldous

Tom Hodge, PhD, formerly with the CDC and now presenting on behalf of Float Pharma,a venture that’s developed a way to identify proteins in the case of COVID-19 don’t’ mutate. According to Hodges this approach “wipes out the virus” and includes therapeutic attributes. In this sense this investigational agent represents the potential for both vaccine and therapeutic but has only been conducted in preclinical research. Their investigational FLOVID-20 uses inhalational delivery of a preventative and therapeutic immuno-stimulatory biomedicine targeted nucleocapsid epitopes on SARS-COV-2. Sponsored by the COVID-19 Early Treatment Fund (CETF) watch to better understand the speaker's point of view.

In an important webinar series sponsored by Steve Kirsch and his COVID-19 Early Treatment Fund (CETF), Farid Jalali presents COVID-19: Serotonin Dysregulation Cause of Pulmonary Vasoregulatory Dysfunction Contributor to Morbidity and Death. In this presentation Farid Jalali discusses Cyproheptadine, an anti-histamine, and its potential use targeting COVID-19. Dr. Jalali shares that based on numerous studies now COVID-19 risks associated with heightened platelet activation representing higher intensity than with other forms of disease escalation such as acute respiratory distress syndrome (ARDS) and sepsis. The doctor argues that elevated serotonin associated with COVID19 is reversible via Cyproheptadine for acute illness. With ongoing studies, some real world data the presenters suggest the potential for Cyproheptadine for select COVID-19 cases. Watch this fascinating video to learn more.

Steve Kirsch, a successful technology entrepreneur and businessman has become a force for the positive during the COVID-19 pandemic. Kirsch has not just advocated for generic, economical repurposed drug strategies to help save more lives, but also went a few steps further than most could ever conceive by investing extensively to launch the COVID-19 Early Treatment Fund (CETF). Recently CETF sponsored a series of presentations by scientists and researchers in the drug development field exploring the use of existing approved therapies (repurposed drugs) that show the potential for efficacy and safety targeting COVID-19. In this video Kirsch and team, including Dr. David Sefteldiscuss the mounting data for both ivermectin and fluvoxamine as potential low cost and highly available generic medicines targeting COVID-19. Follow the link for this compelling, informative and some might think provocatively intriguing discussion. Dr. Seftel’s observational study was showcased on CBS’ 60 Minutes. Also learn about the compelling ivermectin data.